Granular Therapeutics Ltd jobs and careers

About Granular Therapeutics Ltd

In many chronic inflammatory diseases, mast cells are central drivers of pathology. The paucity of mast cell-selective drugs leaves a huge unmet medical need in this area. Targeting of mast cells via indiscriminate blocking of c-KIT signalling, while potentially efficacious, can lead to severe, dose-limiting bone marrow suppression. Granular’s approach targets mast cells specifically & powerfully, for top-down, disease-modifying immune modulation with improved safety profile.